Discovery of novel inhibitors of ghrelin O-acyltransferase enzyme: an in-silico approach
Background and purpose: Ghrelin is known as a hunger hormone and plays a pivotal role in appetite, food intake, energy balance, glucose metabolism, and insulin secretion, making it a potential target for the treatment of obesity and type 2 diabetes. The essential maturation step of ghrelin to activa...
Main Authors: | Faezeh Sadat Hosseini, Alireza Ghassempour, Massoud Amanlou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2022;volume=17;issue=5;spage=540;epage=557;aulast=Hosseini |
Similar Items
-
Ghrelin octanoylation by ghrelin O-acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling
by: Tasha R. Davis, et al.
Published: (2021-07-01) -
Novel regulator of acylated ghrelin, CF801, reduces weight gain, rebound feeding after a fast, and adiposity in mice
by: Martin K Wellman, et al.
Published: (2015-09-01) -
The Interaction of Obesity and Ghrelin/Leptin
by: Aliye Sağkan Öztürk, et al.
Published: (2018-12-01) -
Inhibition of ghrelin o-acyltransferase attenuated lipotoxicity by inducing autophagy via AMPK–mTOR pathway
by: Zhang S, et al.
Published: (2018-04-01) -
Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy
by: Altabas V, et al.
Published: (2015-07-01)